Simple text-messaging system saves time for cancer patients during treatment visits

Cancer patients spend a lot of time on their care. Meeting with doctors and other members of their health care team, getting labs and other tests, picking up prescriptions, and undergoing treatment all takes time.

Risk Adjusted Net Present Value: What is the current valuation of Atara Biotherapeutics’s ATA-3219

The revenue for ATA-3219 is expected to reach an annual total of $70 mn by 2038 in the US based off GlobalData’s Expiry Model. The

December 15, 2024

Novartis’ Scemblix gains FDA approval for leukaemia treatment

In the ASC4FIRST trial, Scemblix showed superior MMR rates at week 48 compared to standard-of-care TKIs and imatinib alone. Credit: Elle Aon/Shutterstock. Novartis has received

October 30, 2024

GTI Revenue and Adjusted EBITDA Were Better Than Expected

CHICAGO and VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a

February 27, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.